Rx only · Injection, Solution · Intramuscular

Glycopyrrolate

Brands: Glyrx-Pf · Glycopyrrolate

11 ACTIVE SUPPLIERS — US

openFDA · updated weekly

US35 NDCs
11 active makers

UKComing
soon

CAComing
soon

AUComing
soon

EUComing
soon

ATCD11AA01

RxCUI (US)1546438

US makers11 labelers

Packages42

DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 7 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$1.394

Latest avg · Jul 22, 2026

-8%

Since Aug 20, 2025

Active US suppliers

33%

Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

8.1K

Rx · 2026 Q1

25K

Units dispensed

-31%

Rx vs. year ago

Quarters · since 2025 Q1

Who makes it11 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

Labeler	Type	Packages	Status
Fresenius Kabi USA, LLC	unknown	10	SUPPLYING
American Regent, Inc.	unknown	4	SUPPLYING
Exela Pharma Sciences, LLC	unknown	4	SUPPLYING
AuroMedics Pharma LLC	unknown	4	SUPPLYING
Piramal Critical Care Inc	unknown	4	SUPPLYING
Henry Schein Inc.	unknown	4	SUPPLYING
Medical Purchasing Solutions, LLC	unknown	3	SUPPLYING
ProPharma Distribution	unknown	3	SUPPLYING
Sagent Pharmaceuticals	unknown	3	SUPPLYING
Amneal Pharmaceuticals LLC	unknown	2	SUPPLYING
Civica, Inc.	unknown	1	SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

Feb 7, 2020
RECALLRecall (Class III): Glycopyrrolate Injection, USP 4 mg per 20 mL (0.2 mg/mL), 20 mL Multiple Dose Vial, Rx Only, For Intramuscular or Intra…
Failed Impurities/Degradation Specifications: elevated levels of Benzaldehyde impurity was found in investigative samples (retain samples). — Recalling firm: AuroMedics Pharma LLC — Ohio, Louisiana, Mississippi